Updates are available Correction dated 2025-01-31
Click to view Correction: https://doi.org/10.1007/s12185-025-03931-3
-
Authors
Kashiwagi, Hirokazu https://orcid.org/0000-0002-4814-8667
Miura, Isao
Terasawa, Naohiko
Iwayama, Ken-ichi
Furukawa, Yuka
Kanenishi, Makoto
-
Funding
Funding for this research was provided by:
Kissei
- License Information
-
More Information
Article History
Received: 25 September 2024
Revised: 3 December 2024
Accepted: 3 December 2024
First Online: 12 December 2024
Change Date: 22 January 2025
Change Type: Update
Change Details: The original online version of this article was revised due to retrospective open access order.
Change Date: 31 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12185-025-03931-3
Declarations
:
: HK is a member of the Editorial Board in International Journal of Hematology, and has received honoraria from Kissei Pharmaceutical Co., Ltd., argenx Japan, Novartis Pharma K.K and Sysmex Corporation. IM, NT and KI are employees of Kissei Pharmaceutical Co., Ltd. YF and MK are employees of Ark Medical Solutions Inc.
: The study was approved by the Institutional Review Board of MINS, a specified nonprofit corporation and was conducted in accordance with the principles of the Declaration of Helsinki. This study protocol was registered in UMIN Clinical Trials Registry (Trial Number: UMIN000052806).
: The requirement for informed consent was waived because of the anonymity of patient data.
